Made $19k on Friday. Made $70 today. Unfortunate reality of trading is when there is no trend, it’s hard to make money.
Can get 1 or 2r, but trending conditions is the formula for bigger winning sessions, not position size.
6 wins, 1 loss this week. Signaled live on @honeydripnet every morning.
Going to reset my account and start from 25k in September. First month, I will take it to 35k live, or else I’ll donate $5k to @RedCross
https://t.co/0OqAjUmovm
If you’re trading an ICT model or any model that’s simple enough to be programmed in a week, your system won’t have edge.
You need some twist to any widely published strategy, otherwise it’s patched.
@CesarTrades01 Yes but there becomes a point where the juice just simply isn’t worth the squeeze. People just holding trades for clout, but aren’t making real money. Equity different story.
If you’re a trader posting 1000% returns, it just shows me you aren’t trading size.
Big returns are great, but real traders lock in and move to the next setup. You think funds managing real size are pulling in 1000%?There are limitations to options. Small gains add up. Compound. Equity- that’s a different story.
This is not financial advice. This is just my idea and my own thoughts. This is not the only stock I own, and my own account is diversified so even if this stops me out, I’m still liquid. Do your own research.
I’m long $KMB at $98 per share
The company behind Huggies, Kleenex, and Scott.
They’ve also received shareholder approval to acquire Kenvue (Tylenol, Motrin, Zyrtec, Listerine).
This creates a global health + essentials powerhouse. A unique win-win scenario is presenting with 30-40% upside potential.
My Discounted Cash Flow suggests without the KVUE acquisition, KMB’s book value is around $117.84 per share, reflecting a 19.4% upside.
The “win-win” scenario-
1. Deal goes through. KMB overpays but they become an “essentials” conglomerate and intrinsic value is around $135 per share.
2. Regulators block the deal. Relief rally.
2026 Public Offerings- the Biggest IPO wave in years
SpaceX
$1.5 – $1.75T valuation
$75B Expected Raise
Mid-late 2026
On target to be the largest IPO ever.
Databricks
$134-160B Valuation
$5-10B Expected Raise
Q2 2026
AI infrastructure company that sits behind how enterprises actually build and run machine learning